Fucosyltransferase 8 (FUT8) is a mammalian enzyme responsible for the addition of fucose in an α1,6 linkage to the innermost N-acetylglucosamine (GlcNAc) residue of N-linked glycans, a process known as core fucosylation. This unique modification is essential for protein maturation, modulating the function of receptors like TGF-β, EGF, and IgG Fc, thereby impacting cell signaling, adhesion, immune response, and development. FUT8 is critically involved in cancer progression and is explored as a target for glycoengineering in antibody therapeutics to increase immune-mediated cytotoxicity. Loss of FUT8 function is associated with lethal developmental phenotypes and impaired organogenesis.
Inhibition: Blockade of FUT8 activity prevents core fucosylation, enhances therapeutic antibody binding to Fcγ receptors, and increases immune effector function. Gene knockout or editing: Used in cell lines to produce afucosylated biotherapeutics with increased efficacy.
03
Biological functions
Core fucosylation of N-linked glycansProtein glycosylationRegulation of receptor activity (including growth factor and immune receptors)Modulation of cell adhesion and signalingEssential for normal development, especially of lung and brain
04
Disease associations
Cancer (contributes to invasiveness, metastasis, and malignant potential)Congenital disorders of glycosylationNeurodevelopmental diseasePulmonary disease (emphysema-like lung changes in knockout models)Liver disease (steatosis-like phenotype in transgenic models)Other (role in immune modulation via IgG glycosylation)
05
Safety considerations
Complete loss of FUT8 leads to severe developmental defects (growth retardation, lung damage, reduced survival)Systemic inhibition may disrupt essential glycoprotein maturation and signaling
06
Interacting drugs
No approved drugs, but enzyme is considered a target for therapeutic glycoengineering (e.g., to enhance antibody-dependent cellular cytotoxicity in monoclonal antibody therapeutics)
07
Biomarkers
Increased FUT8 expression correlates with cancer progression and metastasisCore fucosylation levels in glycoproteins, especially antibodies or serum proteins, may serve as biomarkers for FUT8 activity
Beyond the preview
Go deeper on Fucosyltransferase 8 (FUT8).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fucosyltransferase 8 (FUT8).